MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 10800-10807

  Xiao, Peng ^a   Liu, Wen Liang ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Cell proliferation; HMGB1; MicroRNA; NSCLC (Non small cell carcinoma)

Indexed keywords

3' UNTRANSLATED REGION; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, HUMAN; MICRORNA; MIRN142 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; AGED; APOPTOSIS; BINDING SITE; BIOLOGY; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETIC TRANSFECTION; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; SIGNAL TRANSDUCTION; TIME FACTOR; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; AGED; APOPTOSIS; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGB1 PROTEIN; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 85012963417     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I; EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007; 8: 784-796.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
4. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
5. Calin GA and Croce CM. MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 2006; 25: 6202-6210.
6. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003; 113: 673-676.
7. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
8. Liu Y, Zhao J, Zhang PY, Zhang Y, Sun SY, Yu SY and Xi QS. MicroRNA-10b targets E-cadherin and modulates breast cancer metastasis. Med Sci Monit 2012; 18: BR299-308.
9. Li WQ, Li YM, Tao BB, Lu YC, Hu GH, Liu HM, He J, Xu Y and Yu HY. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance. Med Sci Monit 2010; 16: HY27-30.
10. Shang C, Lu YM and Meng LR. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit 2012; 18: BR149-155.
11. Wu L, Cai C, Wang X, Liu M, Li X and Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett 2011; 585: 1322-1330.
12. Shen WW, Zeng Z, Zhu WX and Fu GH. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med (Berl) 2013; 91: 989-1000.
13. MacKenzie TN, Mujumdar N, Banerjee S, Sangwan V, Sarver A, Vickers S, Subramanian S and Saluja AK. Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation. Mol Cancer Ther 2013; 12: 1266-1275.
14. Namlos HM, Meza-Zepeda LA, Baroy T, Ostensen IH, Kresse SH, Kuijjer ML, Serra M, Burger H, Cleton-Jansen AM and Myklebost O. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 2012; 7: e48086.
15. Shang C, Hong Y, Guo Y, Liu YH and Xue YX. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A. Med Sci Monit 2014; 20: 2571-2577.
16. Tanuma S, Yagi T and Johnson GS. Endogenous ADP ribosylation of high mobility group proteins 1 and 2 and histone H1 following DNA damage in intact cells. Arch Biochem Biophys 1985; 237: 38-42.
17. Ulloa L and Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 2006; 17: 189-201.
18. Ferrari S, Finelli P, Rocchi M and Bianchi ME. The active gene that encodes human high mobility group 1 protein (HMG1) contains introns and maps to chromosome 13. Genomics 1996; 35: 367-371.
19. Tanuma S and Johnson GS. ADP-ribosylation of nonhistone high mobility group proteins in intact cells. J Biol Chem 1983; 258: 4067-4070.
20. Rauvala H, Huttunen HJ, Fages C, Kaksonen M, Kinnunen T, Imai S, Raulo E and Kilpelainen I. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. Matrix Biol 2000; 19: 377-387.
21. Flohr AM, Rogalla P, Meiboom M, Borrmann L, Krohn M, Thode-Halle B and Bullerdiek J. Variation of HMGB1 expression in breast cancer. Anticancer Res 2001; 21: 3881-3885.
22. Bartling B, Hofmann HS, Weigle B, Silber RE and Simm A. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 2005; 26: 293-301.
23. Brezniceanu ML, Volp K, Bosser S, Solbach C, Lichter P, Joos S and Zornig M. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 2003; 17: 1295-1297.
24. Volp K, Brezniceanu ML, Bosser S, Brabletz T, Kirchner T, Gottel D, Joos S and Zornig M. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 2006; 55: 234-242.
25. Poser I and Bosserhoff AK. Transcription factors involved in development and progression of malignant melanoma. Histol Histopathol 2004; 19: 173-188.
26. Liu PL, Tsai JR, Hwang JJ, Chou SH, Cheng YJ, Lin FY, Chen YL, Hung CY, Chen WC, Chen YH and Chong IW. High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. Am J Respir Cell Mol Biol 2010; 43: 530-538.
27. Wang C, Fei G, Liu Z, Li Q, Xu Z and Ren T. HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cells. Cancer Biol Ther 2012; 13: 727-736.
28. Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT and Tsung A. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 2012; 55: 1863-1875.